BRCA1 mRNA expression modifies the effect of T cell activation score on patient survival in breast cancer.

BRCA1 expression modified the effect of T cell activation status on patient survival in breast cancer, suggesting that the existence of neoantigens and the enhancement of neoantigen presentation in combination with immune checkpoint blockade may have synergistic effects on patient outcome.